跳至主要内容
临床试验/NCT07710638
NCT07710638进行中(未招募)2 期

A Prospective Randomized Controlled Clinical Trial to Evaluate the Efficacy of Oral and Topical Ivermectin in the Treatment of Plane Warts

Al-Azhar University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年6月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
80
试验地点
1
主要终点
percentage of patients achieving complete clearance of plane warts

研究概览

简要总结

This study aims to evaluate the efficacy of ivermectin in the treatment of plane warts( flat warts). patients diagnosed with plane warts will be included to assess the clearance ratre of the lesions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical and dermoscopic diagnosis of the plane warts.
  • No prior treatment for warts in the last 4 weeks.
  • Patients of both sex (male - female)
  • Age more than 5 years or weight more than 15 kg.

排除标准

  • • Patients with other types of warts (e.g., common, plantar, genital).
  • History of hypersensitivity or allergy to ivermectin or its components.
  • Patients who have received systemic immunosuppressive therapy within the last 3 months.
  • Presence of chronic skin conditions that may interfere with evaluation (e.g., eczema, psoriasis).
  • Patients with immunodeficiency disorders (e.g., HIV, organ transplant recipients).
  • Pregnant or lactating females.
  • Patients currently on systemic antiviral or immunomodulatory treatment.

结局指标

主要结局

percentage of patients achieving complete clearance of plane warts

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Alfoully Ahmed

Resident of dermatology

Al-Azhar University

研究点 (1)

Loading locations...

相似试验